Casdin Partners Master Fund, L.P. Verve Therapeutics, Inc. (VERV) insider trading activity

Casdin Partners Master Fund, L.P. is > 10% Shareholder of Verve Therapeutics, Inc.. Currently has a direct ownership of 2.42 Million shares of VERV, which is worth approximately $12.7 Million. The most recent transaction as insider was on Jun 21, 2021, when has been sold 1,100,000 shares (Common Stock) at a price of $19.0 per share, resulting in proceeds of $20,900,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.42M

0% 3M change

0% 12M change

Total Value Held $12.7 Million

Casdin Partners Master Fund, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jun 21 2021	BUY Open market or private purchase	$20,900,000 $19.0 p/Share	1,100,000 Added 31.27%	2,417,596 Common Stock
Jun 21 2021	BUY Conversion of derivative security	-	1,317,596 Added 50.0%	1,317,596 Common Stock

Also insider at

BLFS

BIOLIFE SOLUTIONS INC Healthcare

> 10% Shareholder

DBTX

Decibel Therapeutics, Inc. Healthcare

> 10% Shareholder

ABSI

Absci Corp Healthcare

Director

MXCT

MAXCYTE, INC. Healthcare

> 10% Shareholder

TNYA

Tenaya Therapeutics, Inc. Healthcare

> 10% Shareholder

LAB

STANDARD BIOTOOLS INC. Healthcare

Director

CPM